nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00367	0.00367	CcSEcCtD
Betahistine—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Betahistine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Betahistine—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Betahistine—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Betahistine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Betahistine—Vasodilation procedure—Doxorubicin—peripheral nervous system neoplasm	0.00359	0.00359	CcSEcCtD
Betahistine—Vasodilation—Doxorubicin—peripheral nervous system neoplasm	0.00359	0.00359	CcSEcCtD
Betahistine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Betahistine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Betahistine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00357	0.00357	CcSEcCtD
Betahistine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00357	0.00357	CcSEcCtD
Betahistine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00354	0.00354	CcSEcCtD
Betahistine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00352	0.00352	CcSEcCtD
Betahistine—Ventricular extrasystoles—Doxorubicin—peripheral nervous system neoplasm	0.0035	0.0035	CcSEcCtD
Betahistine—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.00341	0.00341	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00338	0.00338	CcSEcCtD
Betahistine—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Betahistine—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Betahistine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.0033	0.0033	CcSEcCtD
Betahistine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Betahistine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Betahistine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Betahistine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Betahistine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Betahistine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Betahistine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Betahistine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Betahistine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Betahistine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00319	0.00319	CcSEcCtD
Betahistine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00319	0.00319	CcSEcCtD
Betahistine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Betahistine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Betahistine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Betahistine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Betahistine—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Betahistine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00313	0.00313	CcSEcCtD
Betahistine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00313	0.00313	CcSEcCtD
Betahistine—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Betahistine—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Betahistine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Betahistine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Betahistine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Betahistine—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Betahistine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Betahistine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Betahistine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Betahistine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Betahistine—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00288	0.00288	CcSEcCtD
Betahistine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00288	0.00288	CcSEcCtD
Betahistine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Betahistine—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Betahistine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Betahistine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Betahistine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Betahistine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Betahistine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Betahistine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Betahistine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Betahistine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Betahistine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Betahistine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Betahistine—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Betahistine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00268	0.00268	CcSEcCtD
Betahistine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00267	0.00267	CcSEcCtD
Betahistine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Betahistine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Betahistine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Betahistine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Betahistine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Betahistine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Betahistine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Betahistine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Betahistine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Betahistine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Betahistine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Betahistine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Betahistine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Betahistine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Betahistine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Betahistine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Betahistine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Betahistine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Betahistine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Betahistine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Betahistine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Betahistine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Betahistine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Betahistine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Betahistine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Betahistine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Betahistine—Malaise—Etoposide—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Betahistine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Betahistine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Betahistine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Betahistine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Betahistine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Betahistine—Rash—Topotecan—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Betahistine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Betahistine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Betahistine—Headache—Topotecan—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Betahistine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Betahistine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Betahistine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Betahistine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Betahistine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Betahistine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Betahistine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Betahistine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Betahistine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Betahistine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Betahistine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Betahistine—Headache—Tretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Betahistine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Betahistine—Rash—Melphalan—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Betahistine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Betahistine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Betahistine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Betahistine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Betahistine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Betahistine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Betahistine—Nausea—Topotecan—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Betahistine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Betahistine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Betahistine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Betahistine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Betahistine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Betahistine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Betahistine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Betahistine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Betahistine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Betahistine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Betahistine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Betahistine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Betahistine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Betahistine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Betahistine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Betahistine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Betahistine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Betahistine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Betahistine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Betahistine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Betahistine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Betahistine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Betahistine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Betahistine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Betahistine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Betahistine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Betahistine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Betahistine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Betahistine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Betahistine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Betahistine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Betahistine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Betahistine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Betahistine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Betahistine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Betahistine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Betahistine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Betahistine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Betahistine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Betahistine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Betahistine—Rash—Vincristine—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Betahistine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Betahistine—Headache—Vincristine—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Betahistine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Betahistine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Betahistine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Betahistine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Betahistine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Betahistine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Betahistine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Betahistine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Betahistine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Betahistine—Rash—Cisplatin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Betahistine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Betahistine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Betahistine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Betahistine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Betahistine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Betahistine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Betahistine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Betahistine—Rash—Etoposide—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Betahistine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Betahistine—Headache—Etoposide—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Betahistine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Betahistine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Betahistine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Betahistine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Betahistine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Betahistine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Betahistine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Betahistine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Betahistine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Betahistine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Betahistine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Betahistine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Betahistine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Betahistine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Betahistine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Betahistine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000992	0.000992	CcSEcCtD
Betahistine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000973	0.000973	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000972	0.000972	CcSEcCtD
Betahistine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000968	0.000968	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000929	0.000929	CcSEcCtD
Betahistine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000897	0.000897	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000895	0.000895	CcSEcCtD
Betahistine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000874	0.000874	CcSEcCtD
Betahistine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000862	0.000862	CcSEcCtD
Betahistine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000833	0.000833	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00083	0.00083	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000809	0.000809	CcSEcCtD
Betahistine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000805	0.000805	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000797	0.000797	CcSEcCtD
Betahistine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000774	0.000774	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000771	0.000771	CcSEcCtD
Betahistine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000768	0.000768	CcSEcCtD
Betahistine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000767	0.000767	CcSEcCtD
Betahistine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000763	0.000763	CcSEcCtD
Betahistine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000745	0.000745	CcSEcCtD
Betahistine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000723	0.000723	CcSEcCtD
Betahistine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000717	0.000717	CcSEcCtD
Betahistine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000711	0.000711	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.00071	CcSEcCtD
Betahistine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000706	0.000706	CcSEcCtD
Betahistine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.000669	CcSEcCtD
